Seelos therapeutics to participate in two upcoming healthcare conferences

New york , may 22, 2023 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel) ("seelos"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in two upcoming healthcare conferences: the benchmark healthcare house call virtual conference to be held on may 23 rd; and the 2023 jefferies global healthcare conference to be held in new york city, ny, on june 7-9, 2023. seelos senior management will host one-on-one and small group meetings in the benchmark healthcare house call virtual conference on may 23 rd.
SEEL Ratings Summary
SEEL Quant Ranking